School of Medicine
Showing 1-100 of 222 Results
-
Demir Akin, D.V.M., Ph.D.
Deputy Director, Center for Cancer Nanotechnology Excellence, Rad/Canary Center at Stanford for Cancer Early Detection
Current Role at StanfordDeputy Director, Center for Cancer Nanotechnology Excellence for Translational Diagnostics
-
Israt Alam
Senior Research Scientist-Basic Life, Rad/Molecular Imaging Program at Stanford
BioResearch Focus and interests: Molecular Imaging, PET, Immuno-Oncology, Graft versus Host Disease, CAR T cells
Dr. Israt Alam is a Senior Scientist in the Radiology Department at Stanford University. She trained in Prof. Sanjiv Sam Gambhir's lab and transitioned to Dr. Michelle James' lab in 2021. Her research focuses on studying lymphocyte activation with the motivation of developing non-invasive imaging tools, to monitor immune dynamics in response to cancer immunotherapy and in immunopathology. Her work has supported the clinical translation of several nuclear imaging agents (small molecules and a biologic) for early detection of cancer and prediction of treatment response. She has also worked on several biomarker detection platforms for early disease detection. She is currently co-chair of the "Imaging in cell and immune therapies" (ICIT) interest group for the World Molecular Imaging Society (WMIS).
Appointments:
-Senior Research Scientist, James Lab, Department of Radiology, Stanford
-Life Sciences Research Associate, Gambhir Lab, Department of Radiology, Stanford
-Post-Doctoral Scholar, Gambhir Lab, Department of Radiology, Stanford
-Visiting Researcher /Churchill Travel Fellow in the Plateforme d'imagerie dynamique lab of Prof. Spencer Shorte, Pasteur Institute, Paris
-Science Education Consultant: United Nations Educational, Science and Cultural Organization (UNESCO), Paris
-Science Education Intern: United Nations Educational, Science and Cultural Organization (UNESCO), Paris -
David Anders
Director, Cyclotron and Radiochemistry Facility, Rad/Molecular Imaging Program at Stanford
Current Role at StanfordDirector of the Cyclotron and Radiochemistry Facility
The CRF team is excited to be designing our second cyclotron facility where we will expand production into radiometals. -
Robin Augustine
Basic Life Research Scientist, Rad/Pediatric Radiology
Current Role at StanfordDr. Robin Augustine's current research interests revolve around three fascinating areas: graphene-based bioscaffolds, islet transplantation, and synchronized cellular response.
In the field of graphene-based bioscaffolds, Dr. Augustine actively explores the potential of graphene as a biomaterial for tissue engineering. With its unique properties, graphene offers exceptional opportunities for developing innovative bioscaffolds. Dr. Augustine aims to design and engineer graphene-based materials that can provide structural support, promote cellular adhesion and growth, and enhance tissue regeneration. Leveraging the exceptional properties of graphene, such as its mechanical strength, electrical conductivity, and biocompatibility, Dr. Augustine's goal is to contribute to the development of advanced bioscaffolds for various applications in regenerative medicine.
Another area of Dr. Augustine's research focuses on islet transplantation, particularly in the context of treating diabetes. Islet transplantation holds promise as a potential cure for type 1 diabetes, involving the transfer of insulin-producing islet cells into the recipient's pancreas. Dr. Augustine investigates strategies to optimize islet transplantation techniques, improve the long-term viability of transplanted islets, and enhance their functionality. The ultimate objective is to contribute to the development of more effective and sustainable approaches for islet transplantation, with the aim of improving the quality of life for individuals living with diabetes.
Dr. Augustine also explores the field of synchronized cellular response, recognizing its crucial role in tissue development, regeneration, and repair. The focus is on understanding and manipulating the synchronized cellular response in complex tissue systems. By studying the intricate signaling pathways and cellular interactions, Dr. Augustine aims to identify key factors and mechanisms that regulate coordinated cellular behavior. This knowledge can inform the development of strategies to enhance tissue regeneration and repair processes, potentially leading to improved outcomes in various biomedical applications.
Through research in graphene-based bioscaffolds, islet transplantation, and synchronized cellular response, Dr. Augustine strives to contribute to the advancement of tissue engineering, regenerative medicine, and the development of innovative therapies for complex medical challenges. -
Vikram S Bajaj
Adjunct Professor, Rad/Molecular Imaging Program at Stanford
BioAdj. Professor, Stanford Radiology.
Managing Director, Foresite Capital Management
Co-Founder/CEO, Foresite Labs
Previous:
Chief Scientific Officer, GRAIL
Chief Scientific Officer and Co-Founder, Verily (Google Life Sciences) -
Indrani Bhattacharya
Research Engineer, Rad/Integrative Biomedical Imaging Informatics at Stanford
Current Role at StanfordAcademic Staff -- Research, working on developing Artificial Intelligence methods that integrate complementary multimodal data for disease detection and aggressiveness characterization.
-
Serena Bonaretti
Physical Sci Res Assoc, Rad/Musculoskeletal Imaging, Rad/Musculoskeletal Imaging
BioPlease visit My Personal Site and the JOINT Group Website (Links on the right)
-
Thomas Brosnan
Research scientist, Rad/Radiological Sciences Laboratory
Current Role at StanfordOffline data reconstruction and display; architecture and programming support for clinical research MR scans; image data transfer; image display; troubleshooting; data encryption and security.
-
Tracy Burk
Sr. Program Manager, Quality and Clinical Initiatives, Rad/Radiology Finance and Administration
Current Role at StanfordSr. Program Manager, Quality and Clinical Initiatives
Department of Radiology, Stanford School of Medicine
Program Manager, Stanford/Intermountain Healthcare Collaboration Grant Program -
Edwin Chang
Director, Small Animal Imaging Facility at Porter Drive, Rad/Molecular Imaging Program at Stanford
Current Role at StanfordDirector, SCI3@Porter or the Canary Core Preclinical Imaging Facility at Stanford
-
Tyler Edward Cork
Ph.D. Student in Bioengineering, admitted Autumn 2018
Temp - Non-Exempt, Rad/Radiological Sciences LaboratoryCurrent Research and Scholarly InterestsCurrently, I am involved in two main projects. The first is developing 3D printing techniques to improve the accuracy of ex vivo geometrical and microstructural cardiac modeling from in vivo cardiac MR acquisitions. The second is applying machine learning applications to MRI data as a way to improve overall image quality and reduce acquisition time.
-
Bao Do
Clinical Associate Professor (Affiliated), Rad/Musculoskeletal Imaging
Staff, Radiology - Diagnostic RadiologyBioClinical Associate Professor of Radiology (Affiliated), Stanford University
VISN21 Chief of Radiology Informatics, Dept of Veterans Affairs
Residency: Diagnostic Radiology University of Iowa, Stanford University
Fellowship: Musculoskeletal / Thoracic, Stanford University
www.stanford.edu/~baodo -
Frezghi Habte
Director, Stanford Center for Innovations in In vivo Imaging (SCi3), Stanford Center for Innovation and In Vivo Imaging
Current Role at StanfordDirector, Stanford Center for Innovation, in In vivo Imaging
-
Ka Chun Ho
Lab Assistant I, Rad/Molecular Imaging Program at Stanford
Current Role at StanfordLab Assistant I - Stanford University, Cyclotron & Radiochemistry Facility
-
Gunilla B Jacobson
Director, Translational Medicine and Technical & Strategic Director, Cyclotron, Rad/Precision Health and Integrated Diagnostics
Current Role at StanfordDirector of Translational Medicine, DeSimone Lab
Technical and Strategic Director, Cyclotron -
Mausam Kalita
Physical Science Research Professional 2, Rad/Molecular Imaging Program at Stanford
Current Role at StanfordSenior Research Scientist: a) cold chemical synthesis— Synthesis of the 12C and 19F- HPLC standards and precursors for 11C- and 18F- labeling
b) Radiosynthesis— Introduction of 11C or 18F radioisotopes into small molecules to develop novel PET tracers, that can track activated myeloid cells in neurodegenerative disease, c) radiometal labeling— 64Cu and 89Zr labeling of monoclonal antibodies that target immune receptors, d) clinical translation— To follow FDA guidelines for translating preclinically validated tracers into humans in the cyclotron and radiochemistry facility (CRF) of the Stanford University -
Johanna Kim
Executive Director, Center for Artificial Intelligence in Medicine and Imaging, Rad/Thoracic Imaging
BioI’m an accomplished healthtech leader with deep experience in launching & leading research teams. I’m directly responsible for building programs and partnerships, leading teams through all phases of research. I’m especially adept at cultivating interdisciplinary and academic/industry collaborations and navigating complexities inherent to the healthcare space.
My work has supported development of novel technologies and applications, helped to generate substantial research funding, and contributed to numerous high-impact publications. My career has spanned diverse contexts, including academic medical centers, university research labs, and health clinics. My passion for people, operations, and the belief that technology can improve health has been the driving force of my career for the last 20 years.
Of all the things I value most in my career, working for a meaningful cause is at the top of the list. I enjoy working with brilliant clinicians, scientists and engineers who have bold, audacious ideas to improve human health. I thrive in “start-up” cultures where collaboration and excitement are the norm, bringing cross-disciplinary and cross-functional teams together to incubate new solutions. I love the satisfaction that comes from working with a close-knit team to develop and deploy innovations in clinical practice. -
Jeffrey Howard Kleck
Adjunct Professor, Rad/Molecular Imaging Program at Stanford
BioJeff Kleck, Ph.D., is an Adjunct Professor at Stanford University and a prominent figure in the Silicon Valley tech venture community. As an established technology and software entrepreneur, he has successfully guided several ventures from concept to becoming market leaders, even taking them public on the NASDAQ. Jeff's leadership roles have included Founder, CEO, and Chairman, shaping these ventures into influential commercial entities.
Currently serving as a Senior Partner at Elevens, Jeff is instrumental in leveraging the expertise of some of the foremost AI minds globally to accelerate breakthrough ventures across multiple sectors. His commitment to advancing technology extends to his role as a Special Government Expert (SGE) for the United States Government, where he acts as a Senior Advisor, identifying and delivering advanced technology for national security. Jeff's previous role as a Highly Qualified Expert (HQE) involved directing transformative and strategic capabilities, promoting the adoption of innovative commercial technologies to enhance national security.
Jeff's involvement in academia is extensive, having served as a visiting scientist at Lawrence Berkeley National Laboratory and Los Alamos National Laboratory, as well as an Adjunct Professor at the University of California Los Angeles (UCLA). His formal education spans various engineering, medical applied science, and technology disciplines, earning a Ph.D. in Biomedical Physics from UCLA, an MS in Engineering Management from Stanford University, an MS in Nuclear Engineering from Texas A&M University, and a BS in Nuclear Engineering from the same institution.
In addition to his contributions at Stanford and Elevens, Jeff has taken on significant roles for the Vatican. Currently, as the Dean of Academics at Catholic Institute of Technology (CIT), he orchestrates cross-disciplinary initiatives, harmonizing theoretical foundations with real-world applications and fostering a culture of innovation. Simultaneously, Jeff serves as the Chairman of Entrepreneurship and Technology Commercialization at CIT, leading the charge in blending academic excellence with practical innovation and overseeing programs that fuse entrepreneurial principles with cutting-edge technology for holistic education.
Jeff is also actively engaged in various ventures, including his role as Chairman of Open Power & Energy Network (OPEN), where he is dedicated to shepherding OPEN toward achieving a sustainable future by seamlessly integrating cutting-edge technologies and best practices, renewing the global climate through accessible power and energy solutions. Additionally, Jeff supports Playground Global, a premier hard tech venture capital firm, as a Friend of Playground.
With a wealth of experience and a commitment to driving innovation, Jeff Kleck continues to shape the landscape of technology, academia, and entrepreneurship.
Reference
Catholic Institute of Technology - https://catholic.tech
Elevens - https://www.elevens.ai
LinkedIn - https://www.linkedin.com/in/jeff-kleck-a000299/
OPEN - https://openpowerenergy.net
Playground - http://playground.vc
